Search tips
Search criteria 


Logo of acsmedlettACS PublicationsThis JournalSearchSubmit a manuscript
ACS Medicinal Chemistry Letters
ACS Med Chem Lett. 2017 September 14; 8(9): 987.
Published online 2017 September 1. doi:  10.1021/acsmedchemlett.7b00353
PMCID: PMC5601380

Correction to “Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma”

Due to an oversight by the corresponding author, one author, Dr. Catherine Leblanc, was inadvertently omitted from the published manuscript [ACS Med. Chem. Lett.2017, 8 (5), 582–586]. The correct author list is as follows:

David A. Sandham, Lucy Barker, Lyndon Brown, Zarin Brown, David Budd, Steven J. Charlton, Devnandan Chatterjee, Brian Cox, Gerald Dubois, Nicholas Duggan, Edward Hall, Julia Hatto, Catherine Leblanc, Janet Maas, Jodie Manini, Rachael Profit, Darren Riddy, Catherine Ritchie, Bindi Sohal, Duncan Shaw, Rowan Stringer, David A. Sykes, Matthew Thomas, Katharine L. Turner, Simon J. Watson, Ryan West, Elisabeth Willard, Gareth Williams, and Jennifer Willis.

Articles from ACS Medicinal Chemistry Letters are provided here courtesy of American Chemical Society